Newly-formed biotech developing an acquired therapy for endocrine disorders.
Industry: Health Care
First Day Return: -11.6%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 09/30/2016 |
Offer Price | $15.00 |
Price Range $12.00 - $15.00 | |
Offer Shares (mm) | 14.5 |
Deal Size ($mm) | $218 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 10/26/2016 |
Offer Price | IPO Intelligence Only |
Price Range | IPO Intelligence Only |
Offer Shares (mm) | IPO Intelligence Only |
Deal Size ($mm) | $218 |
Lock-Up Date | IPO Intelligence Only |
Street Research | IPO Intelligence Only |
Underwriters |
---|
IPO Intelligence Only |
Company Data | |
---|---|
Headquarters | Hamilton, Bermuda |
Founded | 2016 |
Employees at IPO | 9 |
Website www.myovant.com |